BELGRADE, Mont., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), formerly Bacterin International
Holdings, Inc., a leader in the development of class-leading regenerative medicine products and medical devices, today announced
that its Chief Executive Officer, Dan Goldberger and Chief Scientific Officer, Dr. David Kirschman will present at the Canaccord
Genuity 2016 Musculoskeletal Conference, to be held March 1st, 2016 at the Hyatt Regency Orlando. Xtant Medical's presentation will
take place Tuesday, March 1st from 11:30AM-12:00PM Eastern Time.
A live broadcast of the conference presentation will be available. To access the broadcast, go to the "Investor Info" section of
the Company's website at www.xtantmedical.com. A replay of the conference presentation will also be available.
About Xtant Medical Holdings
Xtant Medical Holdings, Inc. (NYSE MKT:XTNT) develops, manufactures and markets class-leading regenerative medicine products and
medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological
surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal
disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and
ankle surgeries. With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources
to successfully compete in global neurological and orthopedic surgery markets. For further information, please visit www.xtantmedical.com.
Important Cautions Regarding Forward-looking Statements
This press release contains certain disclosures that may be deemed forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995 that are subject to significant risks and uncertainties. Forward-looking statements
include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words
such as "continue," "efforts," "expects," "anticipates," "intends," "plans," "believes," "estimates," "projects," "forecasts,"
"strategy," "will," "goal," "target," "prospects," "potential," "optimistic," "confident," "likely," "probable" or similar
expressions or the negative thereof. Statements of historical fact also may be deemed to be forward-looking statements. We caution
that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a
variety of important factors, including, among others: the Company's ability to successfully integrate the acquisition of X-spine;
the ability of the Company's sales force to achieve expected results, the Company's ability to meet its existing and anticipated
contractual obligations, including financial covenant and other obligations contained in the Company's secured lending facility;
the Company's ability to manage cash flow; the Company's ability to develop, market, sell and distribute desirable applications,
products and services and to protect its intellectual property; the ability of the Company's customers to pay and the timeliness of
such payments; the Company's ability to obtain financing as and when needed; changes in consumer demands and preferences; the
Company's ability to attract and retain management and employees with appropriate skills and expertise; the impact of changes in
market, legal and regulatory conditions and in the applicable business environment, including actions of competitors; and other
factors. Additional risk factors are listed in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q under
the heading "Risk Factors." You should carefully consider the trends, risks and uncertainties described in this document, the Form
10-K and other reports filed with or furnished to the SEC before making any investment decision with respect to our securities. If
any of these trends, risks or uncertainties actually occurs or continues, our business, financial condition or operating results
could be materially adversely affected, the trading prices of our securities could decline, and you could lose all or part of your
investment. The Company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect
events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by
law. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their
entirety by this cautionary statement.
Contact: COCKRELL GROUP 877.889.1972 investorrelations@thecockrellgroup.com cockrellgroup.com